A.C., N., C.D., M., S., R., H., A., A.Y., S., M.K., S., . . . PHARMACOLOGY. (2018). Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS).
Chicago Style CitationA.C., Nirvanappa, et al. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS), 2018.
MLA引文A.C., Nirvanappa, et al. Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. Public Library of Science (PLoS), 2018.
警告：這些引文格式不一定是100％准確.